Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Navan, Inc. (NASDAQ: NAVN): Grabar Law Office is Investigating Claims on Your Behalf

BMI Faces Active Shareholder Investigation Over Fiduciary Duty Claims

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>&lt;link type=&quot;text/css&quot; rel=&quot;stylesheet&quot; href=&quot;https://www.globenewswire.com/styles/gnw_nitf.css&quot;&gt;&lt;/li...</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>Grabar Law Office has launched an investigation into BMI for fiduciary breaches, joining a broader campaign of shareholder actions disclosed in the release. The catalyst is a federal securities suit alleging that BMI overstated demand and that accelerated orders masked weakness through 2025-2026. If the matter proceeds, BMI could face governance changes, settlements, and continued stock volatility.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>Grabar Law Office probes BMI for fiduciary breaches. Investigation targets officers and directors.</li><li>Alleges revenue masking via order pull-forward. 2025-2026 results weakened.</li><li>BMI stock fell after disappointing quarters. Legal action may pressure valuation.</li><li>Investors invited to join inquiry. No-cost recovery options discussed.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>Badger Meter, Inc. (BMI)</strong>: Subject of fiduciary-duty investigation; governance risk.</li><li><strong>GeneDx Holdings Corp. (WGS)</strong>: Also targeted in related securities action; cross-company notice.</li><li><strong>GRAIL, Inc. (GRAL)</strong>: Facing shareholder governance probes; potential market impact on life-science sector.</li><li><strong>Navan, Inc. (NAVN)</strong>: IPO-disclosure scrutiny; governance risk and potential claims.</li></ul>
  </section>

  <section data-block="category">
    <h3>Legal</h3>
    <p>Category Analysis: Legal. The BMI item is part of a broader multi-company fiduciary-duty and securities-law inquiry, highlighting governance and compliance risk for investors.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Legal investigation headlines pose near-term volatility for BMI.</li><li>Resolution pace and settlement details will drive any recovery in BMI.</li><li>Governance changes or settlements could affect BMI&#039;s future cash flow.</li><li>Regulatory/legal risk may spill over to peers in the sector.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Grabar Law Office investigation announced June 29, 2026.</li><li>BMI investors who bought before April 18, 2024 may pursue claims.</li><li>Allegations include acceleration/pull-forward of orders masking demand.</li><li>Disappointing 2025-2026 quarters cited (revenue, margins, utility sales).</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term downside risk as legal probes weigh on BMI; resolution or settlements could alter the valuation trajectory.</p>
  </section>
</section>


<article>
  <p><strong>Opening Note</strong>: Grabar Law Office has announced investigations focusing on Badger Meter, Inc. (NYSE: BMI) and GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of shareholders. The firm’s inquiries assess whether certain officers and directors breached their fiduciary duties to their respective companies. The announcements were issued on June 29, 2026 from Philadelphia, PA.</p>

  <section aria-label="Badger Meter investigation">
    <h2>Badger Meter, Inc. Investigation By Grabar Law Office (BMI)</h2>

    <p><strong>Company</strong>: Badger Meter, Inc. <strong>(NYSE: BMI)</strong></p>

    <p><strong>What is happening?</strong> Grabar Law Office is investigating claims on behalf of shareholders Badger Meter, Inc. (NYSE: BMI). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p>

    <p><strong>Who may be affected?</strong> Investors who purchased or acquired Badger Meter shares prior to <strong>April 18, 2024</strong> and still hold BMI stock today may be eligible to participate in potential corporate reforms, the return of funds back to the company, and a court‑approved incentive award at no cost to them. </p>

    <p>For more information, visit the BMI shareholder investigation page or contact the firm directly:
      <ul>
        <li><strong>https://grabarlaw.com/the-latest/bmi-shareholder-investigation/</strong></li>
        <li><strong>Contact:</strong> jgrabar@grabarlaw.com</li>
        <li><strong>Phone:</strong> 267-507-6085</li>
      </ul>
    </p>

    <p><strong>Why?</strong> A recently filed federal securities class action alleges that Badger Meter, Inc. (NYSE: BMI), through certain of its officers, repeatedly attributed its strong financial performance to favorable industry trends, robust customer demand, growing adoption of its AMI offerings, strong order activity, backlog conversion, and long-term growth opportunities. According to the complaint, investors were allegedly led to believe that the Company’s financial performance reflected sustainable, demand-driven growth and strong underlying business fundamentals.</p>

    <p>The complaint further alleges that Badger Meter's reported results were materially impacted by the acceleration or pull-forward of customer orders, which allegedly masked weakening demand trends and depleted future-period revenue opportunities. As a result, investors allegedly received an inaccurate picture of the Company’s near-term growth prospects and the sustainability of its financial performance. It is alleged that the truth emerged through a series of disappointing quarterly announcements during 2025 and 2026, including reports of slowing revenue growth, declining margins, lower utility water sales, weaker municipal customer ordering activity, and reduced earnings performance. Following these announcements, Badger Meter’s stock price experienced significant declines.</p>

    <p><strong>What can you do now?</strong> If you purchased or acquired Badger Meter shares prior to <strong>April 18, 2024</strong> and still hold BMI stock today, you are encouraged to visit the BMI investigation page cited above, or contact Grabar Law Office to learn more. The firm notes that investors can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. </p>

    <p><strong>Format note</strong>: The information above is presented for informational purposes and reflects the public notices issued by Grabar Law Office related to BMI and related actions.</p>

  </section>

  <section aria-label="GeneDx investigation">
    <h2>GeneDx Holdings Corp. Investigation By Grabar Law Office (WGS)</h2>

    <p><strong>Company</strong>: GeneDx Holdings Corp. <strong>(NASDAQ: WGS)</strong></p>

    <p><strong>What is happening?</strong> Grabar Law Office is investigating claims on behalf of shareholders GeneDx Holdings Corp. (NASDAQ: WGS). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.</p>

    <p><strong>Who may be affected?</strong> Investors who purchased or acquired GeneDx shares prior to <strong>April 16, 2025</strong> and still hold GeneDx stock today may be eligible to participate in potential corporate reforms, the return of funds back to the company, and a court‑approved incentive award at no cost to them.</p>

    <p>For more information, visit the GeneDx shareholder investigation page or contact the firm directly:
      <ul>
        <li><strong>https://grabarlaw.com/the-latest/genedx-shareholder-investigation/</strong></li>
        <li><strong>Contact:</strong> jgrabar@grabarlaw.com</li>
        <li><strong>Phone:</strong> 267-507-6085</li>
      </ul>
    </p>

    <p><strong>Why?</strong> As alleged in a recently filed securities fraud class action, GeneDx Holdings Corp. (NASDAQ: WGS), through certain of its executives, violated federal securities laws by making false and/or misleading statements pertaining to the impact of the Fabric acquisition on the overall business of the Company. It is alleged that WGS repeatedly made statements that would have caused the average investor to believe that the Fabric acquisition would improve the Company’s financials and create efficiencies between it and the Company’s core business. These include statements such as: <em>“There is room to run in terms of reducing COGS in the future by combining the best of capability between GeneDx and Fabric as we lean into the best possible algorithms to optimize dry lab processes.”</em> These and similar statements when made were false. In truth, it is alleged, Defendants knew of, or recklessly disregarded, significant problems in Fabric’s viability that would negatively impact WGS’s overall business and operations. As a result, the Company’s statements concerning its business, operations, and prospects lacked a reasonable factual basis.</p>

    <p><strong>What can you do now?</strong> If you purchased GeneDx shares prior to <strong>April 16, 2025</strong> and still hold WGS stock today, you can seek corporate reforms, the return of funds back to the company, and a court‑approved incentive award at no cost to you whatsoever. The firm provides the same contact channels as described above for BMI investors.</p>

  </section>

  <section aria-label="Key facts and context">
    <h2>Key Facts and Context for BMI and WGS Investigations</h2>
    <ul>
      <li><strong>Grabar Law Office</strong> is the investigative firm referenced in connection with BMI and WGS shareholder claims.</li>
      <li><strong>BMI</strong> and <strong>WGS</strong> are the primary symbols involved in the investigations reported on June 29, 2026.</li>
      <li><strong>Dates of potential eligibility</strong>: BMI investors may have purchased before <strong>April 18, 2024</strong>; GeneDx investors may have purchased before <strong>April 16, 2025</strong>.</li>
      <li><strong>Potential remedies</strong> include corporate reforms, return of funds to the company, and a court‑approved incentive award, at no cost to shareholders.</li>
      <li><strong>Public action</strong> includes a federal securities class action alleging misstatements related to company performance and acquisitions for both BMI and WGS cases.</li>
    </ul>
  </section>

  <section aria-label="Closing and contact information">
    <h2>How to Learn More</h2>
    <p>Shareholders who may be eligible are encouraged to visit the investigation pages linked above or contact Grabar Law Office directly for guidance on potential participation in any proposed settlements or reforms. This coverage provides a high-level overview of the claims and does not constitute legal advice.</p>
  </section>
</article>

Grabar Law Office has launched an investigation into BMI for fiduciary breaches, joining a broader campaign of shareholder actions disclosed in the release. The catalyst is a federal securities suit alleging that BMI overstated demand and that accelerated orders masked weakness through 2025-2026. If the matter proceeds, BMI could face governance changes, settlements, and continued stock volatility.

important-notice-to-long-term-shareholders-of-badger-meter-inc-nyse-bmi-genedx-holdings-corp-nasdaq-wgs-grail-inc-nasdaq-gral-and-navan-inc-nasdaq-navn-grabar-law-office-is-investigating-claims-on-your-behalf

Important Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Navan, Inc. (NASDAQ: NAVN): Grabar Law Office is Investigating Claims on Your Behalf

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Legal

Related News